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Noncanonical Function of
Glutamyl-Prolyl-tRNA Synthetase:
Gene-Specific Silencing of Translation
Introduction
Translational control of gene expression can be global
and regulate synthesis of many proteins, or it can be
transcript selective and influence expression of a small
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(Mukhopadhyay et al., 1997). Translational silencing re-
quires binding of the interferon-gamma-activated inhibi-
Summary tor of translation (GAIT) protein (or complex) to a 29 nt
element in the Cp mRNA 3UTR (Sampath et al., 2003).
Aminoacyl tRNA synthetases (ARS) catalyze the li- The GAIT element has a stem-loop structure containing
gation of amino acids to cognate tRNAs. Chordate two invariant residues essential for activity (Sampath et
ARSs have evolved distinctive features absent from al., 2003). We have shown by a yeast three-hybrid screen
that ribosomal protein L13a interacts with the Cp 3UTRancestral forms, including compartmentalization in a
GAIT element and that L13a is required for translationalmultisynthetase complex (MSC), noncatalytic peptide
silencing activity in IFN--treated cells (Mazumder et al.,appendages, and ancillary functions unrelated to
2003a). Furthermore, L13a phosphorylation causes itsaminoacylation. Here, we show that glutamyl-prolyl-
release from the large ribosomal subunit.tRNA synthetase (GluProRS), a bifunctional ARS of
Here, we have used the GAIT element as an RNAthe MSC, has a regulated, noncanonical activity that
affinity ligand to purify additional GAIT element bindingblocks synthesis of a specific protein. GluProRS was
proteins and have identified glutamyl-prolyl-tRNA syn-identified as a component of the interferon (IFN)-
thetase (GluProRS) as a key component of the GAITgamma-activated inhibitor of translation (GAIT) com-
complex. Aminoacyl tRNA synthetases (ARS) catalyzeplex by RNA affinity chromatography using the cerulo-
the ligation of amino acids to specific tRNAs and areplasmin (Cp) GAIT element as ligand. In response to
biochemically responsible for implementation of the ge-
IFN-, GluProRS is phosphorylated and released from
netic code (Ribas de Pouplana and Schimmel, 2001).
the MSC, binds the Cp 3-untranslated region in an The bifunctional GluProRS is present in higher eukary-
mRNP containing three additional proteins, and si- otic cells, and its catalysis of two amino acids to their
lences Cp mRNA translation. Thus, GluProRS has di- cognate tRNAs is unique (Cerini et al., 1991). It is a
vergent functions in protein synthesis: in the MSC, 163 kDa monomer consisting of the catalytic domains
its aminoacylation activity supports global translation, separated by a peptide linker. GluProRS is a component
but translocation of GluProRS to an inflammation- of the aminoacyl-tRNA multisynthetase complex (MSC)
responsive mRNP causes gene-specific translational containing seven other ARSs and three noncatalytic
silencing. components, p18, p38, and p43 (Han et al., 2003; Rob-
inson et al., 2000). The functions of these smaller pro-
teins are uncertain, but p38 may provide a scaffold for
assembly and maintenance of the MSC (Kim et al., 2002).*Correspondence: foxp@ccf.org
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Several vertebrate ARSs have activities unrelated to binding proteins were identified: GluProRS, NS1-associ-
ated protein-1 (NSAP1, also called heterogenous nuclearaminoacylation (Francklyn et al., 2002). The majority of
ARSs with noncanonical functions have appended do- ribonucleoprotein Q1), and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). We were unable to obtainmains not present in the ancestral proteins (Shiba, 2002).
However, a noncanonical function for GluProRS has not mass spectrometric data from one stained band that
specifically eluted from the wild-type column (openbeen reported. In this report, we elucidate a pathway
of GluProRS activation involving phosphorylation and arrow); its electrophoretic mobility was similar to that
of phospho-L13a, and immunoblot analysis showedrelease from the MSC, and subsequent formation of a
complex with three other proteins. This complex binds L13a in the wild-type eluate (Figure 2A, right).
The presence of the four proteins in the GAIT mRNPthe 3UTR GAIT element of Cp mRNA and specifically
suppresses its translation. was tested by immunodepletion of the cytosolic extract,
followed by RNA EMSA; formation of the RNA-protein
complex was markedly inhibited by each antibody (Fig-Results
ure 2B). Their presence was confirmed by supershift
analysis using the same antibodies (data not shown).Identification of the Protein Components
The function of the depleted lysates was also markedlyof the GAIT Complex
suppressed, as shown by in vitro translation of a heterol-We tested whether ribosomal protein L13a by itself
ogous reporter (Figure 2C). Together, these results showbinds the GAIT element by RNA electrophoretic mobility
that GluProRS, GAPDH, and NSAP1, in addition to L13a,shift assay (EMSA). As shown before (Sampath et al.,
are components of the functional GAIT mRNP.2003), lysates from U937 cells treated with IFN- for 24
hr but not for 8 hr contain a GAIT element binding protein
or complex (Figure 1A). Recombinant, insect cell- IFN- Mobilizes GluProRS from the MSC
and Induces Two-Stage Assemblyderived human L13a, which is phosphorylated and si-
lences in vitro translation of a GAIT element-containing of the GAIT mRNP
To explore the mechanism of induction of translationalreporter transcript (Mazumder et al., 2003a), did not by
itself bind the GAIT element (Figure 1A). However, bind- silencing activity, we examined whether IFN- induced
expression of the GAIT mRNP components. We haveing was reconstituted upon coaddition of phospho-L13a
and cytosolic extract from cells treated with IFN- for previously shown that L13a is not induced (but is phos-
phorylated) upon IFN- treatment (Mazumder et al.,8 hr; extracts from untreated cells were inactive. Binding
specificity was shown by competition with wild-type 2003a). Immunoblot analysis showed that neither the
expression nor the apparent molecular size of Glu-but not mutant GAIT element oligonucleotides. E. coli-
derived L13a, which is not phosphorylated and does not ProRS, NSAP1, and GAPDH was altered by IFN- (Figure
3A). We considered the possibility of regulated translo-inhibit reporter transcript translation, did not bind the
GAIT element under any conditions. Thus, a component cation of GAIT mRNP components from other cytosolic
complexes. A strategy coupling size fractionation to im-in the 8 hr lysate is required for interaction of phospho-
L13a with the GAIT element. munoblot analysis permitted unbiased detection of
movement of all mRNP components. About 90% of theTo assess whether the GAIT mRNA ribonucleoprotein
complex (mRNP) contains additional proteins, the mo- cellular GluProRS in untreated cells is in high molecular
weight fractions consistent with the 1.5-mDa MSC, alecular mass was determined. Cytosol from cells treated
with IFN- for 24 hr was subjected to gel filtration (Figure finding confirmed by colocalization of p38, an integral
MSC protein (Figure 3B, top panels). The remainder was1B, top). The peak of GAIT element binding activity,
measured by RNA EMSA, corresponded to a size of in the low molecular weight fractions consistent with free
enzyme. L13a was primarily in high molecular weightabout 450 kDa (Figure 1B, middle). Transcript-specific
translation inhibition was measured in an in vitro transla- fractions consistent with its ribosomal localization.
NSAP1 and GAPDH were almost exclusively in low mo-tion assay using luciferase (Luc)-Cp GAIT element-
poly-A RNA as a heterologous reporter (Figure 1B, bot- lecular weight fractions consistent with an unbound
form. None of the four GAIT proteins was detected intom). Specificity was shown by simultaneous translation
of T7 gene 10, a transcript lacking the GAIT element. the intermediate fractions corresponding to the active
fractions. Treatment of cells with IFN- for 8 hr showedThe results were consistent with the binding data and
indicated that the GAIT mRNP is approximately 450 kDa. shifts in two proteins. About 55% of the GluProRS origi-
nally in the high molecular weight fractions translocatedGAIT mRNP proteins were isolated by affinity chroma-
tography using 5-biotinylated GAIT element RNA as to the region corresponding to active fractions (Figure
3B, middle panels). Likewise, the majority of the NSAP1ligand (Figure 2A, left). We took advantage of a mutated
(U87C) GAIT element that is inactive with respect to shifted from the low molecular weight fractions to colo-
calize with GluProRS in the active fractions. The elutionmRNP formation and translational silencing activity
(Sampath et al., 2003). Cytosol from IFN--treated cells positions of GAPDH and L13a were unchanged. These
results suggest formation of a binary, pre-GAIT complexwas applied to columns containing 5-biotinylated wild-
type or mutant GAIT element and eluted with salt. The consisting of GluProRS and NSAP1 by 8 hr of IFN-
treatment. After 24 hr, all four proteins were detected ineluates were resolved by SDS-PAGE and were silver
stained (Figure 2A, center). Protein bands specifically the fractions containing the active GAIT complex (Figure
3B, lower panels). Consistent with our previous report,eluted from the wild-type column were subjected to
tryptic digestion and sequenced by liquid chromatogra- essentially all L13a in the high molecular weight, ribo-
somal fraction was mobilized (Mazumder et al., 2003a).phy-tandem mass spectrometry. Three GAIT element
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Figure 1. The GAIT mRNP Is a Large, Multicomponent Complex
(A) L13a by itself does not bind the GAIT element. U937 cells were incubated with IFN- for 8 or 24 hr and cytosolic lysates (lys.) prepared.
Recombinant, full-length human L13a (rL13a) was expressed and partially purified from baculovirus-infected insect cells or E. coli. Binding
of cell lysates and recombinant L13a to 32P-labeled, 29 nt GAIT element RNA was analyzed by EMSA. Specificity was tested by competition
with a 10-fold molar excess of unlabeled, wild-type (wt), or mutant (Mut.) GAIT element.
(B) Size exclusion chromatography indicates that GAIT is a large, multicomponent complex. Cells were treated with IFN- for 24 hr and the
S100 fraction of the cell lysate (3 mg protein) subjected to Superose 6 size exclusion chromatography. Eluted protein was detected by
absorbance at 280 nm and compared to protein size markers (top, line alone). Binding of fractions to radiolabeled, 29 nt human Cp 3UTR
GAIT element was determined by RNA EMSA (middle) and quantitated by densitometry (top, ). Translational silencing activity of the fractions
(bottom left) (and unfractionated cell lysates, bottom right) was measured by in vitro translation of capped, Luc-Cp GAIT element-poly(A)
cRNA in rabbit reticulocyte lysate containing [35S]methionine (top, ). Capped, T7 gene 10 cRNA was added as a control to show specificity
of the inhibition.
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Figure 2. RNA Affinity Chromatography
Identifies GluProRS, NSAP1, and GAPDH as
Components of the GAIT mRNP
(A) Determination of specifically bound pro-
teins. Cells were treated with IFN- for 24 hr,
and the lysate (4 mg of protein) was pre-
cleared with scrambled GAIT and mutant
GAIT element oligomers. Cleared lysate was
incubated with biotinylated wild-type or mu-
tant GAIT element (left) and then with strep-
tavidin microbeads. Specifically bound pro-
tein was eluted with buffer containing 300 mM
NaCl and samples subjected to SDS-PAGE
and silver staining (center). Trypsinized bands
were analyzed by liquid chromatography-
tandem mass spectrometry to give peptide
sequences. A major silver-stained band had
an electrophoretic mobility consistent with
phosphorylated L13a (center, open arrow)
but was not identifiable by mass spectrome-
try. Immunoblot analysis of samples with anti-
L13a antibody shows L13a in the GAIT
mRNP (right).
(B) Verification of proteins in the GAIT mRNP
by RNA EMSA. U937 cells were treated with
IFN- for 8 or 24 hr. The 24 hr cell lysate was
subjected to gel filtration, and active fractions
were pooled and subjected to immunodeple-
tion with antibodies against candidate pro-
teins GluProRS, NSAP1, GAPDH, and L13a or
with anti-p38, IgG, and monoclonal antibody
SP2/O as control antibodies. Binding to ra-
diolabeled GAIT element was determined by
RNA EMSA.
(C) In vitro translation confirms that identified
proteins are components of a functional GAIT
mRNP. The loss of translational silencing ac-
tivity of the cell lysates after specific immuno-
depletion was examined by their effect on
in vitro translation of the chimeric Luc re-
porter as described above.
These results suggest a two-stage assembly of the precipitation procedure verified that GluProRS and
NSAP1 are interacting partners in the pre-GAIT complexGAIT complex.
The appearance of GluProRS in the intermediate frac- (Figure 4A, top left). Cycloheximide, at a concentration
that inhibited total protein synthesis by about 90%, didtions coincides with its disappearance from the high
molecular weight fractions, suggesting that the MSC is not inhibit formation of this complex (Figure 4A, top
right). Immunoblot analysis with LysRS (Figure 4A,the source of GluProRS in the pre-GAIT complex. Two
other sources of GluProRS in the pre-GAIT complex middle panel) and NSAP1 (Figure 4A, bottom panel) as
markers of the multisynthetase and pre-GAIT com-should be considered: the free cytoplasmic pool and
protein from de novo synthesis. The size fractionation plexes, respectively, verified the effectiveness of the
immunoprecipitation procedure and the specificity ofexperiment excludes the free pool as a major source of
GluProRS, since the amount is insufficient to account the GluProRS shift. Thus, GluProRS in the pre-GAIT
complex is not derived from de novo synthesis. Togetherfor that subsequently found in the active fractions. To
test de novo synthesis as a source of GluProRS, pre- these experiments show that IFN- not only mobilizes
L13a from the large ribosomal subunit but also inducesGAIT complex formation was determined by coimmuno-
precipitation of NSAP1 and GluProRS, under conditions release of GluProRS from its parent MSC.
Our finding that a substantial amount of GluProRS inin which protein synthesis was blocked. The coimmuno-
Noncanonical Function of GluProRS
199
Figure 3. IFN- Induces Release of GluProRS from the MSC
(A) IFN- does not alter expression of GAIT mRNP components. Cell lysates from IFN--treated U937 cells were subjected to immunoblot
analysis using anti-GluProRS, -NSAP1, and -GAPDH antibodies.
(B) IFN- induces stepwise mobilization of proteins into pre-GAIT and GAIT complexes. Lysates from U937 cells treated with IFN- for 0 (top),
8 (middle), or 24 (bottom) hr were subjected to Superose-6 gel filtration chromatography and 2 ml fractions were collected. Fractions
corresponding to active fractions (numbers 14–17) in the 24 hr lysate are denoted by bars. Fractions were analyzed by immunoblot analysis
using antibodies (Abs) against GAIT mRNP components and anti-p38 as an indicator of the MSC.
IFN--treated cells leaves the MSC raises the possibility L13a from the ribosome) without compromising the
overall cellular capacity for translation.that global protein synthesis is perturbed. However,
metabolic labeling with [35S]Met shows that the overall Cofractionation does not prove interaction of the GAIT
complex proteins. These interactions were examinedrate of protein synthesis is unchanged (Figure 4B). Thus,
IFN- induces release of GluProRS from the MSC (and by immunoprecipitation studies. Fractions in the active
Cell
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Figure 4. Protein-Protein Interactions in the Pre-GAIT and GAIT Complexes
(A) GluProRS in the pre-GAIT complex is derived from the MSC, not from de novo synthesis. U937 cells were preincubated with cycloheximide
(50 g/ml) for 30 min and then with IFN- for 8 hr. Cell lysates were immunoprecipitated with antibodies against p38 and NSAP1 to isolate
the multisynthetase and pre-GAIT complex, respectively. Isolated complexes were probed by immunoblot analysis using antibodies against
GluProRS (top), LysRS (middle), and NSAP1 (bottom).
(B) Release of GluProRS from the MSC does not alter global protein synthesis. U937 cells were incubated with IFN- for 8 or 24 hr and then
metabolically labeled by incubation for 2 hr with [35S]methionine in methionine-free medium. Control cells were labeled without IFN- treatment.
An aliquot of the lysates was resolved by SDS-PAGE and detected by fluorography.
(C) Coimmunoprecipitation shows interaction of GluProRS with NSAP1 in the pre-GAIT complex and interaction of all four proteins in the
active GAIT mRNP. Cells were treated with IFN- and subjected to gel filtration as in Figure 3B. Column fractions corresponding to the active
fractions (numbers 14–17) were pooled and immunoprecipitated (IP) using anti-NSAP1 antibody (or IgG as control) and protein-A Sepharose
beads. Precipitates were analyzed by immunoblot using antibodies against GluProRS (top panel), NSAP1 (second panel), GAPDH (third panel),
or L13a (bottom panel).
region of the elution profile were pooled, immunoprecip- GluProRS Release from the MSC
Requires Phosphorylationitated with antibody directed against NSAP1, and sub-
jected to immunoblot analysis. The experiment con- Several ARSs, including GluProRS (Venema and Traugh,
1991), are subject to phosphorylation, but in no case isfirmed that NSAP1 interacted only with GluProRS during
the assembly of the pre-GAIT complex and that all four the function of phosphorylation known (Pendergast and
Traugh, 1985). Metabolic labeling of cells with 32P-ortho-proteins were subsequently joined to form the active
GAIT complex (Figure 4C). phosphate showed that IFN- induced phosphorylation
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of GluProRS by 8 hr and that phosphorylation continued The GAIT Complex Binds the Cp 3UTR via an
for at least 24 hr (Figure 5A). A radiolabeled band consis- Interaction of GluProRS with the GAIT Element
tent with phospho-L13a was also observed, in agree- We have examined the specific role of GluProRS in inhib-
ment with our previous findings (Mazumder et al., 2003a). iting Cp translation. Direct binding of GluProRS to the
Immunoprecipitation of GluProRS and immunoblot anal- Cp GAIT element is an attractive possibility in view of
ysis with phosphospecific antibodies showed phos- the three RNA binding domains in GluProRS, i.e., the
phorylation of GluProRS on serine but not on threonine two tRNA binding sites and the central linker, which has
or tyrosine (Figure 5B). nonspecific RNA binding activity (Cahuzac et al., 2000;
The temporal relationship between phosphorylation Jeong et al., 2000). Protein size was determined by ultra-
and release of GluProRS was examined. GluProRS violet crosslinking to radiolabeled GAIT element RNA.
phosphorylation, detected with anti-phosphoserine an- A labeled complex of about 170 kDa, a size consistent
tibody, was seen after 1 hr of IFN- treatment (Figure 5C, with GluProRS, was formed in the presence of wild-
first and second panels). GluProRS mobilization from the type but not mutant GAIT element probe (Figure 6A). As
MSC was measured by its appearance in the pre-GAIT expected, crosslinking was seen after IFN- treatment
complex in association with NSAP1. Lysates were im- for 24 hr but not for 8 hr. To verify the presence of
munoprecipitated with anti-NSAP1 antibody and bound GluProRS, the crosslinked complex was immunoprecip-
GluProRS detected by immunoblot analysis (NSAP1 was itated, in the presence of detergent, with antibodies
probed as recovery control). GluProRS was detected in against the GAIT mRNP proteins. Only anti-GluProRS
the pre-GAIT complex after 2 hr of IFN- treatment, precipitated the labeled RNA/protein complex (Figure
showing that phosphorylation precedes mobilization by 6B). Since crosslinking can result from proximity rather
about 1–2 hr (Figure 5C, third and fourth panels). Since than actual binding, we tested purified GAIT proteins by
appearance of GluProRS in the pre-GAIT complex may RNA EMSA. GluProRS formed an RNA-protein complex
not coincide with its release from the MSC, the latter with the wild-type GAIT element, but NSAP1, GAPDH,
was examined directly. The MSC was immunoprecipi- and phospho-L13a all failed to bind (Figure 6C). Thus,
tated with anti-p38 antibody and GluProRS detected by GluProRS is the GAIT mRNP protein that directly binds
immunoblot analysis (LysRS was probed as recovery the GAIT element.
control). The disappearance of GluProRS from the MSC In vivo binding of the GAIT complex to Cp mRNA was
nearly coincided with its appearance in the pre-GAIT examined. Lysates were immunoprecipitated with anti-
complex (Figure 5C, fifth and sixth panels). Densitomet- GluProRS, and extracted RNA was subjected to RT-
ric analysis indicates that 60%–80% of the GluProRS is PCR using Cp 3UTR-specific primers (Mazumder et al.,
released, a conclusion consistent with the 55% release 2003a). Amplification of lysates not subjected to immu-
calculated by size fractionation (Figure 5C, bottom noprecipitation showed that Cp mRNA was induced in
panel). cells treated with IFN- for 8 or 24 hr, as expected (Figure
To determine whether GluProRS phosphorylation is 6D, top). Cp mRNA was complexed to GluProRS only in
required for IFN--mediated translocation, cells were cells treated with IFN- for 24 hr. In control experiments,
pretreated with inhibitors of serine/threonine kinases: immunoprecipitation with IgG or elimination of the re-
staurosporine, a relatively nonspecific inhibitor; and H-7, verse transcriptase step (Figure 6D, bottom) gave no
an inhibitor with partial selectivity for protein kinases A amplification of Cp mRNA. Thus, GluProRS in the holo-
and C (Hidaka et al., 1984). In a control experiment, GAIT complex (present at 24 hr) but not in the pre-GAIT
staurosporine and H-7 completely blocked IFN-- complex (present at 8 hr) binds the Cp 3UTR in IFN--
induced GluProRS phosphorylation (Figure 5D, top treated cells.
panel). HA-1004, a structural analog of H-7 with much
lower activity, was ineffective. The release of GluProRS
Discussionfrom the multisynthetase and its appearance in the pre-
GAIT complex were determined by immunoprecipitation
Our experiments suggest a two-stage pathway for for-with anti-p38 and anti-NSAP1 antibodies, respectively.
mation of the GAIT mRNP in IFN--treated monocyticThe precipitates were probed with anti-GluProRS anti-
cells (Figure 7). During the early stage, which takes aboutbody and with anti-LysRS and -NSAP1 antibodies as
4 hr, GluProRS becomes phosphorylated and escapescontrols. Staurosporine and H-7 (but not HA-1004) com-
from the MSC. GluProRS phosphorylation induces bind-pletely inhibited GluProRS release from the MSC and
ing to NSAP1 to form the binary, pre-GAIT complex thatits appearance in the pre-GAIT complex, indicating that
is not competent to bind the Cp GAIT element. AboutGluProRS phosphorylation is required for release (Figure
12 hr later, L13a is phosphorylated and released from5D, lower three panels). Lysates were treated with alka-
the 60S ribosomal subunit (Mazumder et al., 2003a) toline phosphatase to determine whether dephosphoryla-
join GAPDH and the pre-GAIT complex, forming the ma-tion of GluProRS could dissociate the pre-GAIT com-
ture GAIT mRNP. This complex, via interaction of Glu-plex. In a control experiment, phosphatase treatment
ProRS with the GAIT element, binds Cp mRNA andcompletely dephosphorylated GluProRS (Figure 5E, top
blocks its translation. The four GAIT components arepanel). The multisynthetase and pre-GAIT complexes
housekeeping proteins abundant in most if not all cells.were isolated and probed as above. The phosphatase
This observation may explain the paradoxical findingcompletely dissociated GluProRS from NSAP1, indicat-
that phospho-L13a by itself inhibits in vitro translationing that GluProRS phosphorylation is required for the
of a GAIT element-containing reporter RNA (Mazumderinteraction and that phosphorylation is an initiating
et al., 2003a) but does not bind the GAIT element in anevent in the formation of the GAIT mRNP (Figure 5E,
lower three panels). RNA EMSA. In the translation assay, phospho-L13a is
Cell
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Figure 5. Phosphorylation Is Required for GluProRS Release from the MSC
(A) Metabolic labeling shows that IFN- induces GluProRS phosphorylation. U937 cells were incubated with IFN- and then with a 6 hr pulse
of 32P-orthophosphate between 5 and 11 hr (denoted 8 hr) or between 21 and 27 hr (denoted 24 hr). Lysates were immunoprecipitated with
anti-GluProRS antibody (or IgG) and labeled proteins detected by autoradiography.
(B) IFN- induces serine phosphorylation of GluProRS. Lysates from cells treated with IFN- for 8 hr were immunoprecipitated with anti-GluProRS
antibody and immunoblotted (IB) with antibodies targeted against phosphoserine (P-Ser), phosphothreonine (P-Thr), or phosphotyrosine (P-Tyr).
(C) Phosphorylation of GluProRS precedes its release from MSC. U937 cells were treated with IFN- for up to 8 hr, and lysates were prepared.
To determine GluProRS phosphorylation, the lysate was immunoprecipitated with anti-GluProRS antibody and the pellet immunoblotted with
antibodies against P-Ser (top panel) and GluProRS (second panel). To determine GluProRS binding to NSAP1, the lysate was immunoprecipi-
tated with anti-NSAP1 antibody and the pellet immunoblotted with anti-GluProRS (third panel) and anti-NSAP1 (fourth panel). To examine the
release of GluProRS from the MSC, the lysate was immunoprecipitated with anti-p38 antibody and the pellet immunoblotted with anti-GluProRS
(fifth panel) and anti-LysRS (sixth panel) antibodies. The relative amount of GluProRS in each pool was quantitated by densitometry (bottom
panel). Phospho-GluProRS (P-GluProRS) was normalized by total GluProRS (), GluProRS in the pre-GAIT complex (cpx.) was normalized by
NSAP1 (), and GluProRS in the MSC was normalized by LysRS ().
(D) GluProRS phosphorylation is required for release from the MSC. Cells were incubated with IFN- for 0.5 hr and then staurosporine (1 g/ml,
Stauro.), H-7 (25 M), or HA-1004 (25 M) was added for an additional 3.5 hr and lysates prepared. To show efficiency of the kinase
Noncanonical Function of GluProRS
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likely to be complemented by the GAIT proteins in the ever, other functions have not been seen. We have es-
tablished that IFN- treatment induces GluProRS phos-reticulocyte lysate. More importantly, our findings sup-
port the principle that common, constitutive proteins, phorylation and that the modification is essential for
release from the MSC. The mechanism underlying Glu-even integral components of complexes, e.g., the MSC
and ribosome, are sources of context-specific regula- ProRS release is unknown. Since GluProRS phosphory-
lation precedes its release, the kinase likely recognizestory proteins mobilized to form new complexes with
extraordinary functions. GluProRS while bound to the MSC. In view of our finding
that GluProRS phosphorylation is required not only for
release from the MSC but also for binding to NSAP1, thePhosphorylation of GluProRS and Release
interaction with NSAP1 may facilitate GluProRS release.from the MSC
The MSC of higher eukaryotes contains nine ARS activi-
ties and three noncatalytic proteins (Quevillon et al., Two-Stage Mechanism of Assembly
of GAIT Complex1999; Rho et al., 1999). The function of the complex,
and the basis for selective inclusion of fewer than half The pre-GAIT complex of GluProRS and NSAP1 is
formed after 2–4 hr of IFN- treatment. NSAP1 has beenof the ARSs in the complex, remains poorly understood.
A clue may be found in studies in yeast that have a observed in several RNA binding protein complexes,
and it may have a broad role in RNA-related regulatorysmaller tRNA synthetase complex consisting of MetRS,
GluRS, and Arc1p, a homolog of p43 (Galani et al., 2001). processes (Blanc et al., 2001; Grosset et al., 2000;
Mourelatos et al., 2001). Our experiments show that theWhen assembly of the ARSs into the ternary complex
is prevented by removal of a noncatalytic appendage, pre-GAIT complex does not bind the Cp mRNA GAIT
element and regulate its translation. This result appearsall three components enter the nucleus. Thus, a major
function of the MSC may be sequestration of constituent to conflict with the crosslinking studies that show a
direct interaction of GluProRS with the GAIT element.ARSs in the cytoplasm. Alternatively, the complex may
restrict the access of specific synthetases to cyto- We surmise that NSAP1 obstructs the binding site or
alters the conformation of GluProRS such that it fails toplasmic targets other than tRNA. This idea is consistent
with recent observations that several multisynthetase bind the GAIT element. A similar inhibitory mechanism
has been shown for GRY-RBP (a slightly larger NSAP1components in their unbound forms have activities unre-
lated to protein synthesis; compartmentalization in an isoform) in the apolipoprotein B RNA editing system. In
this case, GRY-RBP binds apobec-1 complementationinaccessible complex may provide a mechanism for reg-
ulation. There are several examples of vertebrate multi- factor and inhibits its binding to apolipoprotein B RNA,
thereby preventing RNA editing (Blanc et al., 2001).synthetase components that exhibit alternate activities
in an unbound form: free MetRS in the nucleolus facili- The interacting domains of GluProRS and NSAP1 have
not been identified. Human GluProRS consists of twotates ribosomal RNA synthesis (Ko et al., 2000), trans-
forming growth factor- induces translocation of p38 to catalytic structures separated by a central linker of three
50 amino acid WHEP domains (Cerini et al., 1991; Fettthe nucleus where it inactivates c-myc (Kim et al., 2003),
and LysRS binds the mast cell transcription factor MITF and Knippers, 1991). NMR studies of individual WHEP
domains show a helix-turn-helix structure with basicand maintains it in an inactive state (Lee et al., 2004).
The mechanism of release from the MSC is not known residues lining one face (Cahuzac et al., 2000; Jeong et
al., 2000). The linker domain may provide the bindingfor any ARS. Removal of the peptide appendage from
certain yeast and mammalian ARSs induces dissocia- site for NSAP1, since it is structurally related to NS1, an
NSAP1 target (Harris et al., 1999). The linker also maytion from the MSC (Galani et al., 2001; Robinson et al.,
2000), but proteolysis as a release mechanism has not provide the site for binding the GAIT element, since RNA
binding activity has been reported (Cahuzac et al., 2000;been reported in vivo. Several ARSs, including GluProRS
and other members of the MSC, are phosphorylated Jeong et al., 2000). The physiological significance of the
RNA binding linker domain has not been elucidated, butin vitro by protein kinases (Venema and Traugh, 1991).
In vivo phosphorylation has been described in reticulo- one report suggests it binds the 3UTR of GluProRS
mRNA, possibly to autoregulate at the level of translationcytes (Pendergast et al., 1987) and in liver (Berg, 1990),
but phosphorylation may be cell type- or condition-spe- (Schray and Knippers, 1991). It is tempting to speculate
that the GluProRS linker binds both NSAP1 and thecific, since attempts to show phosphorylated ARSs in
several cell lines have not been fruitful (Mirande et al., GAIT element, and successful competition by the former
prevents the latter. The specific functions of GAPDH1985). The primary function of ARS phosphorylation is
not likely to be regulation of synthetase activity, since and L13a in the translational silencing mechanism are
unknown. GAPDH is an integral component of the OCA-Sthe effects are generally small (Clemens, 1990); how-
inhibitor, an aliquot of lysate was immunoprecipitated with anti-GluProRS antibody and subjected to immunoblot analysis with anti-phosphoser-
ine antibody (top panel). Lysates were immunoprecipitated with antibodies directed against p38 and NSAP1 to isolate the multisynthetase
and pre-GAIT complexes, respectively. The precipitates were subjected to immunoblot analysis with anti-GluProRS (second panel); the
precipitates were also probed with anti-LysRS (third panel) and anti-NSAP1 (bottom panel) antibodies to show recovery of the multisynthetase
and pre-GAIT complexes, respectively.
(E) GluProRS phosphorylation is required for its interaction with NSAP1 to form the pre-GAIT complex. Lysates from cells treated with IFN-
for 4 hr were incubated with shrimp alkaline phosphatase (PPase) at 37C for 1 hr and then subjected to immunoprecipitation and immunoblot
analysis as in (D).
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Figure 6. GluProRS Interacts with the GAIT Element
(A) Crosslinking identifies an approximately 170 kDa protein that binds the GAIT element. Cells were treated with IFN- for 0, 8, or 24 hr.
Cytosolic lysates (lys.) were incubated with wild-type or mutant 32P-labeled GAIT element and subjected to crosslinking by exposure to
ultraviolet light. Proteins were resolved on SDS-PAGE and RNA-protein complexes visualized by autoradiography.
(B) Immunoprecipitation analysis identifies GluProRS as the GAIT element-interacting protein. Cytosolic extract from cells treated with IFN-
for 24 hr was subjected to ultraviolet crosslinking. The protein mixture was immunoprecipitated under detergent-containing, denaturing
conditions, with antibodies directed against GluProRS, NSAP1, GAPDH, L13a, or p38 (or IgG). Radiolabeled proteins were resolved and
detected by autoradiography.
(C) Purified GluProRS binds the GAIT element in vitro. Purified rat GluProRS (81% identical to human amino acid sequence), rat NSAP1 (99%
identical to human), purified rabbit GAPDH (95% identical to human), and recombinant insect cell-derived human phospho-L13a (100 ng of
each protein) were subjected to RNA EMSA using radiolabeled wild-type (left) and mutant (right) Cp GAIT element probes.
(D) GluProRS binds the GAIT element in vivo. U937 cells were treated with IFN- for 8 or 24 hr. Cytosolic extracts were subjected to
immunoprecipitation with anti-GluProRS antibody or IgG control. RNA was extracted from the immunoprecipitate or from extracts not subjected
to immunoprecipitation (No IP). RNA was subjected to RT-PCR amplification with primers specific for the Cp 3UTR (top). As a control, the
Cp 3UTR was amplified by PCR in the absence of the RT reaction (bottom).
coactivator complex and is a redox-sensitive regulator translational control have been identified (Preiss and
Hentze, 2003); however, the translational silencingof transcription (Zheng et al., 2003). GAPDH may have
a parallel function in translational control, a mechanism mechanism used by the GAIT complex is not yet known.
consistent with the known oxidation functions of Cp.
L13a could, by binding ribosomal RNA, act as a “ribo- Noncanonical Function of GluProRS
in Translation Inhibitionsome trap,” thereby preventing either release or initia-
tion of the large ribosomal subunit. Several mechanisms Several chordate ARSs have noncanonical activities,
i.e., cellular functions unrelated to tRNA aminoacylationby which protein complexes exert transcript-specific
Noncanonical Function of GluProRS
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Figure 7. Two-Stage Model of GAIT Complex Formation
(Francklyn et al., 2002; Ko et al., 2002). Recent attention synthesis of Cp and possibly other inflammatory pro-
teins. Identification of coregulated transcripts may pro-has focused on ARSs containing appendages similar to
the WHEP domains in the linker of GluProRS, i.e., TrpRS, vide clues to the physiological function of GAIT-medi-
ated translational silencing. A pattern search for theHisRS, MetRS, and GlyRS (Shiba, 2002). In chordates,
these ARSs all contain a single copy at either the N GAIT element based on structural and sequence fea-
tures reveals candidate elements in the 3UTR of aboutor C terminus, except for GluProRS, which has three
tandem copies in the central linker. In most cases, the 30 human transcripts (Sampath et al., 2003). Several are
interesting due to their relevance to inflammation andappendage does not contribute to aminoacylation activ-
ity and thus may be involved in other functions. Indeed, injury, e.g., death-associated protein kinase, a serine/
threonine kinase induced by IFN- in U937 cells (Deiss etall but GluProRS have been implicated in noncanonical
activities. Two have extracellular functions related to al., 1995); and Mox1, an NADPH oxidase that produces
superoxide (Suh et al., 1999). Multiple inflammatory pro-cell movement: HisRS is chemotactic for leukocytes
(Howard et al., 2002), and a TrpRS fragment inhibits teins are controlled at the level of translation. For exam-
ple, epithelial cell production of interleukin-18, a specificangiogenesis (Otani et al., 2002). The N-terminal ap-
pendage of GlyRS binds to RNA not associated with its inducer of IFN- transcription, is translationally regu-
lated (Garcia et al., 2003). IFN- mRNA negatively regu-aminoacylation function (Wu et al., 1995), and mutations
cause inherited neuropathies (Antonellis et al., 2003). lates its own translation by formation of an RNA pseu-
doknot, possibly to prevent adverse consequences ofFinally, MetRS enhances ribosomal RNA synthesis (Ko
et al., 2000) and may facilitate transfer of aminoacylated long-term activation by IFN- (Ben-Asouli et al., 2002).
Finally, macrophage products themselves may requiretRNA to elongation factor EF-1 (Kaminska et al., 2001).
Thus, GluProRS joins the other WHEP domain-con- rapid downregulation, and IFN--stimulated expression
of inducible nitric oxide synthase, like Cp, is under stricttaining ARSs in expressing a noncanonical function.
Noncanonical functions are not restricted to ARS with translational control (El-Gayar et al., 2003). We speculate
that the GAIT mRNP and as-yet undiscovered transla-this motif; human TyrRS, which contains a distinct pep-
tide appendage, induces angiogenesis (Wakasugi et al., tional control complexes may be critical inhibitors of
gene expression necessary for the timely resolution of2002), and GlnRS has antiapoptotic activity (Ko et al.,
2001). GluProRS and L13a join an expanding family of inflammation.
translation machinery components, e.g., eIF2 and eIF4E/
Experimental Procedures4E-BP, that are switched by phosphorylation from facili-
tators of global translation to gene-selective modulators
Reagentsof translation (Dever, 2002; Mazumder et al., 2003a).
Rabbit reticulocyte lysate, methionine-free amino acids, and RNasin
Translational silencing of Cp may be a mechanism were from Promega (Madison, WI). Human IFN- was obtained from
by which pathological accumulation of the protein is R&D Systems (Minneapolis, MN), RNase H and Superscript was
from Invitrogen (Gaithersburg, MD), and shrimp alkaline phospha-prevented. Excess Cp in inflammatory sites, in the pres-
tase from Fermentas. Translation grade [35S]methionine was fromence of superoxide, may cause oxidative damage due
NEN-DuPont (Boston, MA). H-7 and HA-1004 were purchased fromto its surface copper (Mukhopadhyay et al., 1997). Alter-
Biomol. Staurosporine, rabbit muscle GAPDH, and other reagentsnatively, limiting Cp accumulation may maximize its bac-
were from Sigma (St. Louis, MO). GluProRS was purified from rat
tericidal activity, which is suppressed at high concentra- liver (Ting et al., 1992). Recombinant human L13a was expressed
tions (Klebanoff, 1992). Thus, the delayed translational in E. coli or insect cells (Mazumder et al., 2003a). Antibodies against
human GluProRS (Kim et al., 2002); GAPDH (Novus); LysRS (Kimsilencing activity may have evolved to limit or terminate
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et al., 2002); L13a (Mazumder et al., 2003a); NSAP1; and against buffer containing SDS and resolved on a 10% SDS-PAGE. After
transfer, blots were probed with rabbit polyclonal antibodies andphospho-Ser, phospho-Thr, and phospho-Tyr (Biodesign) were used
in immunoassays. developed with the ECL system (Amersham Pharmacia).
To prepare recombinant NSAP1, a plasmid DNA encoding rat
GRY-RBP, a larger isoform that contains the entire NSAP1 se- Analysis of GAIT Element Binding Protein
quence, was obtained from Donna Driscoll. Primers with flanking by Ultraviolet Crosslinking
restriction sites were used to amplify NSAP1 by PCR. The product 32P-labeled wild-type or mutant GAIT element RNA oligomers
was gel purified, cloned into the HTa baculovirus vector (HTa- (250,000 cpm) were incubated for 30 min at 4C with cytosolic extract
NSAP1), and used to infect High Five insect cells (Invitrogen). Ly- (20 g of protein) in 20 l of buffer containing KCl (15 mM), DTT
sates were made from cells expressing NSAP1 or empty vector and (0.25 mM), MgCl2 (5 mM), PMSF (0.1 mM), RNasin (40 U), glycerol
purified by Y-PER 6xHis Fusion Protein Purification Kit (Pierce). (10%), and 12 mM HEPES (pH 8.0). The mixture was crosslinked by
Eluted fractions were tested by immunoblot analysis using anti- 10 min exposure to ultraviolet light (1,800 J/cm2) in a Stratalinker
NSAP1 antibody. (Stratagene) at room temperature. Samples were denatured in SDS-
PAGE buffer under reducing condition, and RNA-protein complexes
Binding and In Vitro Translation Assays were analyzed by 10% SDS-PAGE and autoradiography.
Cytosolic lysates were prepared from human U937 monocytic cells
cultured in RPMI 1640 medium containing 10% fetal bovine serum Determination of In Vivo Interaction of GluProRS and Cp
(Sampath et al., 2003). For RNA EMSA, cell lysate (or 100 ng of mRNA by Immunoprecipitation and RT-PCR
purified protein) was incubated with radiolabeled, synthetic tran- Cytosol from U937 cells was subjected to immunoprecipitation us-
scripts of wild-type and mutant Cp 3UTR GAIT elements prepared ing 10 l of anti-GluProRS antibody. GluProRS bound mRNA was
by oligonucleotide-directed transcription (Sampath et al., 2003). For amplified by RT-PCR using primers specific for the 247 nt human
in vitro translation assays, gel-purified Luc-Cp GAIT element-poly(A) Cp 3UTR (Mazumder et al., 2003a).
(200 ng) and T7 gene 10 (100 ng) cRNAs were incubated with cell
extracts (4 g protein) in 35 l of rabbit reticulocyte lysate (Sampath
Metabolic Labeling by [35S]Methionineet al., 2003).
and [32P]Orthophosphate
U937 cells (8 106 cells in 4 ml of RPMI 1640 medium) were collected
Gel Filtration Chromatography of Cell Lysates by centrifugation at 7000  g, resuspended in methionine-free me-
Cytosolic extract (3 mg protein) was applied to a Superose-6 FPLC dium (Invitrogen), and metabolically labeled with a 2 hr pulse of
column and eluted at a flow rate of 0.5 ml/min in buffer containing [35S]methionine. A 5-l aliquot was resolved on 10% SDS-PAGE and
50 mM Tris-HCl (pH 7.6), 50 mM NaCl, 1 mM PMSF, and 1 mM DTT. subjected to fluorography. For [32P]phosphate labeling, cells were
Thyroglobulin (664 kDa), apoferritin (443 kDa), alcohol dehydroge- incubated with a 6 hr pulse of [32P]orthophosphate in phosphate-
nase (150 kDa), bovine serum albumin (66 kDa), and carbonic anhy- free medium (Invitrogen).
drase (29 kDa) were molecular weight standards.
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